STRR
Star Equity Holdings, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$9.92
+1.12%Year over year
Reported trailing growth
- Revenue
- +164.8%
- EBITDA
- —
- EBIT
- -48.8%
- EPS
- -24.4%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +14.4%
- EBITDA
- +290.9%
- EPS
- +124.0%
Three-year CAGR
- Revenue
- -5.0%
- EBITDA
- +72.9%
- EBIT
- +56.2%
- Net income
- +43.3%
- EPS
- +47.6%
- Free cash flow
- -11.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026